Fintel reports that on November 3, 2025, Jefferies reiterated coverage of GSK plc - Depositary Receipt (NYSE:GSK) with a Buy ...
GlaxoSmithKline ( ($GB:GSK) ) has shared an announcement. GSK plc has announced its total voting rights and capital as of October 31, 2025, in ...
US regulators approved GSK Plc’s blood cancer drug, a decision that will allow the company to bring the medicine back to the ...
Cash generated from operations totaled £2.5 billion, with free cash flow of £1.2 billion. GSK declared a dividend of 16 pence ...
GSK acquires exclusive rights from Syndivia for antibody-drug conjugate in prostate cancer: London, UK Tuesday, October 28, 2025, 09:00 Hrs [IST] GSK plc and Syndivia, a private b ...
GSK plc ( NYSE: GSK) and Syndivia on Monday announced an agreement granting GSK exclusive worldwide rights to develop and ...
GSK plc (NYSE:GSK) is one of the best growth stocks under $50 to buy now. In a report released on September 4, David Evans from Kepler Capital maintained a Hold rating on GSK plc (NYSE:GSK), setting a ...
Ariel Investments, an investment management company, released its “Ariel Global Fund” third-quarter investor letter. A copy of the same can be downloaded here. In the third quarter, the fund declined ...
GSK plc ( GSK) Q3 2025 Earnings Call October 29, 2025 8:00 AM EDT Ladies and gentlemen, a very warm welcome to the GSK Q3 2025 Results Call. I'm delighted to be joined today by Emma Walmsley, Luke ...
GSK plc (NYSE:GSK) is one of the best UK stocks to buy right now. On September 2, TD Cowen analyst Steve Scala maintained a Hold rating on GSK plc (NYSE:GSK) and set a price target of $45.00. Is GSK ...
GSK plc is preparing filings for its respiratory syncytial virus (RSV) vaccine in older people following supportive late-stage trial results, a product which could play a vital role as it spins out ...
Aristotle Capital Management, LLC, an investment management company, released its “International Equity Fund” third quarter 2022 investor letter. A copy of the same can be downloaded here. In the ...